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Summary: Creatine kinase isoenzymes showed decreasing thermal stability and increasing lability towards pH changes
in the order: MM, MB, and BB. The three isoenzymes exhibited their highest stability between pH 6.5 and 7.0. At
37 °C and an almost physiological pH of 7.5 the decay constants were 0.025, 0.164, and 0.580 h"1 (MM, MB, and
BB isoenzyme), respectively.
In contrast to free creatine kinase BB, immunoglobulin-linked creatine kinase BB (macro creatine kinase BB, type 1
macro creatine kinase) showed a markedly higher stability; this accounts for the persistence of creatine kinase
BB activity in macro creatine kinasaemia. In addition we identified a second type of macro creatine kinase in patients'
sera, which is also thermostable.
A simple heat inactivation test (20 minutes, 45 °C, immunoinhibition of the M-subunits) differentiates thermostable
macro creatine kinases from thermolabile creatine kinases and thus completes isoenzyme diagnosis.
Stabilität von Makro-Kreatinkinasen und Kreatinkinase-Isoenzymen:
Hitzeinaktivierungs-Test zum Nachweis thermostabiler Kreatinkinasen
Zusammenfassung: In der Reihenfolge Kreatinkinase MM, MB und BB nimmt die Thermostabilität der Isoenzyme ab
und ihre Labilität gegenüber pH-Veränderungen zu. Die höchste Stabilität weisen alle drei Isoenzyme zwischen pH 6.5
und 7.0 auf. Bei 37 °C und einem annähernd physiologischen pH von 7.5 bestimmten wir die folgenden Inaktivie-
rungs-Konstanten: 0.025 h"1 (MM), 0.164 h"1 (MB) und 0.580 h"1 (BB).
Im Gegensatz zur freien Kreatinkinase BB ist die immunglobulingebundene Kreatinkinase BB (Makro-Kreatinkinase
BB, Makro-Kreatinkinase Typ 1) erheblich stabiler. Dies erklärt das Persistieren der BB-Aktivität im Plasma von Pa-
tienten mit Makro-Kreatinkinasämie.
Zusätzlich konnten wir eine zweite, ebenfalls thermostabile Form von Makro-Kreatinkinasen in Patientenseren
identifizieren. Durch einen einfachen Hitze-Inaktivierungs-Test (20 min, 45 °C, Immuninhibition der M-Monomere)
lassen sich die thermostabilen Makro-Kreatinkinasen von den thermolabilen Isöenzymen der Kreatinkinase abgrenzen.
Dieser Test liefert zusätzliche Informationen bei der Isoenzymdiagnostik der Kreatinkinase.
Introduction
In a study on the stability of serum creatine kinase )
Morin (1) postulated that creatine kinase isoenzymes
MM, MB and BB undergo two distinct types of inactiva-
tion: a reversible inactivation based on an oxidative
process and an irreversible one which is caused presum-
ably by thermal inactivation. Moreover, several in-
vestigations indicated that BB is the most unstable of
l) Nonstandard abbreviations used; Creatine kinase: CK, AJP:
creatine-phosphotransferase, EC 2.7.3.2; CK-MM, CK-MB,
CK-BB: Striated muscle type* heart type, brain type creatine
kinase isoenzymes.
all creatine kinase isoenzymes, when exposed to freeze-
thawing, light and/or heating (1-3).
One form of macromolecular creatine kinase demon-
strated in patients' sera was identified as a complex be-
tween creatine kinase BB and immunoglobulins (4-8).
In contrast to uncoupled creatine kinase BB, the immuno-
globulin-linked BB was described as strikingly thermo-
stable (4, 7).
It is the intention of this study to compare the thermal
stability of creatine kinase isoenzymes with that of
macro creatine kinases (two forms), and to define the
conditions of a heat stability test for recognition of
macro creatine kinases in the routine laboratory.
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Materials and Methods
Sera studied
Serum samples were assayed on the same day or kept frozen at
- 20 °C without any additive until used. 23 sera with macro
creatine kinase were detected by the immunoinhibition test
(Merckotest® CK-MB, No. 14326, Merck, Darmstadt, FRG),
showing a characteristically high ratio of "CK-MB** to total
creatine kinase. These sera were investigated further by exclusion
chromatography on Sephadex G-200 (8) or Sephacryl S-300 sf
(210 X 9 mm) to confirm the macro molecular form of creatine
kinase. In every case we identified macro creatine kinase by
electrophoresis in agarose gel, by ion exchange chromatography
and by immunological methods with specific antisera against
creatine kinase isoenzymes and immunoglobulins as described
elsewhere (5,8). Furthermore we characterized two different
forms of macro creatine kinases (types 1 and 2) by their binding
properties towards radiolabeled creatine kinase isoenzymes
(radioelectrophoresis) and protein A-Sepharose CL4B, and by
their Michaelis constants and activation energies'(9,10).
Isoenzyme purification
Human uterus, heart, and skeletal muscle obtained from autopsy
or surgery were used as tissue sources of creatine kinase BB, MB
and MM, respectively. All tissues were homogenized in Tris buffer
(50 mmol/1, pH 7.0) at 20 °C without an SH-protecting agent.
The extracts were clarified by centrifugation (30000 g, 20 mm,
4 °C), and the resulting supernates were applied to a 210 X
9 mm column of DEAE-Sepharose CL-6B (Pharmacia Fine
Chemicals, Uppsala, Sweden) equilibrated with starting buffer
(l mmol/1 Tris, pH 8.5). The selective elution of creatine kinase
isoenzymes was performed by a linear buffer gradient ranging
from 1 to 50 mmol/1 Tris (pH 7.0) and 0 to 500 mmol/1 NaCl.
The enzyme-containing fractions were pooled, ultrafiltrated with
50 mmol/1 Tris buffer (pH 7.0), than concentrated with an Ami-
con concentrator (membrane UM 10, Amicon, Witten, FRG)
and stored at 4 °C. The purity of creatine kinase isoenzyme
preparations was verified by electrophoresis on agarose gel
(No. 745, Sigma Chemie, München, FRG) and by immuno-
precipitation with antibodies against M- and B-subunits
(Nos. 11642 and 11643, Merck, Darmstadt, FRG).
Enzyme assays
Creatine kinase activity was measured at 25 °C with the N-acetyl-
cysteine reactivated method (Boehringer Mannheim, FRG)
according to the recommendations of the German Society of
Clinical Chemistry (11) with an analyzer ACP 5040 (Eppendorf
Gerätebau, Hamburg, FRG). We used inhibiting antibodies
against the M-monomer (immunoinhibition test = Merckotest®
CK-MB) to differentiate the activity of creatine kinase MM
from that of macro creatine kinases in the patients' sera.
Thermal stability studies
Purified human creatine kinase isoenzymes were diluted with
cleared (by filtration), heat-inactivated (l h at 60 °C), pooled
serum to obtain creatine kinase activities ranging from 350 to
550 U/l (25 °C, N-acetyl-cysteine-activated method). Such iso-
enzyme-supplemented sera were stored at 4 °C (pH 7.0) over-
night, and tested by isoenzyme electrophoresis before use.
Patients' or isoenzyme-enriched sera were divided into six 3-ml
portions in polystyrene tubes with caps (55 X 12 mm,
No. 112101, Greiner, Nürtingen, FRG), and the pH was adjusted
at 37 °C (AVL Gas Check Type 937, AVL, Schaffhausen, Swit-
zerland) to 6.0, 6.5,7.0, 7.5, 8.0, and 8.5 with minimal volumes
of HC1 or NaOH. All sera were allowed to remain at room tem-
perature for l h before incubation at 37 °C. Aliquots were taken
periodically, and rapidly cooled in an ice bath before creatine
kinase analysis was performed. The pH value of each sample was
measured before and after the experiment.
Decay constants (Kj) were calculated from the slope of creatine
kinase activities in a semi-logarithmic plot by means of linear
regression. Half lives are then given by ty2 = In
Heat inactivation test
Creatine kinase isoenzymes dissolved in native sera of healthy
volunteers (total creatine kinase activity < 40 U/l, activity after
immunoinhibition < 2 U/l) to give activities from 200 to
500 U/l, served as references, pH-values of macro-creatine
kinase-containing sera and isoenzyme-supplemented sera were
measured before heating the samples for 20,40, and 60 minutes
at 45 °C. Creatine kinase activities were assayed before and after
heat inactivation; the immunoinhibition test was also used in
order to avoid interference in the determination of macro
creatine kinase by creatine kinase MM.
Results
Stability studies
Figures 1.1—1.3 illustrate the thermal stability of creatine
kinase isoenzymes at 37 °C stored in serum matrix (heat-
iriactivated human serum) without antioxidant. Exposed
to 37 °C creatine kinase BB showed a very pronounced
loss of catalytic activity compared with the creatine
kinase MB; this loss is even greater when compared with
the MM isoenzyme. At an almost physiological pH of 7.5
the decay constants of BB, MB, and MM activities were
0.580,0.164,0.025 h"1 (half lives: 1.2,4.2,28.3 hours),
respectively. The three isoenzymes exhibited their highest
stability between pH 6.5 and pH 7.O. Whereas enzyme
activities decreased abruptly at lower pH values, the
decrease was more continuous at basic pHs. Table 1
summarizes the results of our calculations of decay con-
stants. The regression coefficients for the half life curves
ranged from 0.90 to 0.99.
In comparison, the sera of two patients containing pre-
dominantly immunoglobulin G-linked creatine kinase BB
(macro creatine kinase BB, type 1 macro creatine kinase)
showed a markedly higher thermal stability than non-
complexed BB, and in one case (Rud.M.) even exceeded
the stability of creatine kinase MM (fig. 2.1 and tab. 2).
In addition, these complexed creatine kinases BB proved
to be considerably more stable at lower and higher pH
values than the creatine kinase isoenzymes. Evidently,
complex formation between creatine kinase BB and
immunoglobulins leads to protection of enzyme against
thermal degradation and improved its stability towards
pH shifts.
One of the macro creatine kinase BB enzyme activities
(Fro.M.) had an optimal stability at pH-values from 6.5
to 7.0 like isoenzymes MM, MB, and BB, but the other
case (Rud.M.) showed its lowest Kd value at the distinctly
higher pH of 7.4 (tab. 2).
Heat inactivation test
Twenty three different sera from 15 patients with con-
firmed macro creatine kinasaemia (12 of type 1,3 of
type 2) and, for reference purposes, sera supplemented
with creatine kinase BB, MB or MM, were heated at
45 °C. Total activity of macro creatine kinase sera ranged
from 26 to 251 U/l (mean 88 U/l), and 68 per cent of
creatine kinase activity on average was not inhibited by
J, Clin. Chem. Clip. Biochem. /Vol. 19,1981 / No. 10
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Ï
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ï
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Tab. l. Effect of pH on the decay constants of creatine kinase
isoenzymes in serum matrix at 37 °C. The decay rates of
isoenzymes based on 13 measurements (in duplicates) of
creatine kinase activities over a period of 8 hours with-
out the 24 h values. The pHs of samples were measured
immediately before and after experiment.
PH
6.07
6.52
7.04
7.49
7.99
8.43
Kd values (h'1)
Creatine
kinase MM
2.071
0.015
0.021
0.025
0.049
0.509
Creatine
kinase MB
3.112
0.022
0.051
0.164
0.457
2.909
Creatine
kinase BB
13.816
0.382
0.429
0.580
1.120
4.306
1.3
anti-creatine kinase-M antibodies. Evidently, freezing and
thawing of the macro creatine kinase sera increased the
pH value when compared with that of the creatine kinase
isoenzyme references (7.9 ±0.5 versus 7.7 ± 0.4, means
and 2 S-limits).
The results of this inactivation procedure are summarized
in table 3. As expected creatine kinase BB (MB) rapidly
lost its activity, showing 12 (32), 8 (18), and 7 (12)
percent of the initial creatine kinase activities after 20,
40 and 60 minutes, respectively.
In contrast to the other isoenzymes MM indicated a con-
siderably higher stability comparable with macro creatine
kinases. To differentiate heat-stable macro .creatine kinase
from creatine kinase MM we determined the enzyme activ-
ities of the patients' sera and of the BB and MB references
after inhibition with anti-creatine kinase-M. In this way
interference by creatine kinase MM was excluded com-
pletely during the heat inactivation test (fig. 3): After
heating 22 different sera containing macro creatine
kinases (17 of type 1, 5 of type 2) for 20 minutes at
45 °C, activities, determined by the immunoinhibition
test, decreased to 88 ± 25 percent (÷ ± 2s) of the initial
activity, whereas creatine kinase BB (MB) activities were
reduced to residual values of 5 ± 4 (27 ± 11) percent
(÷ ± 2s, 16 determinations in seven days).
Discussion
As reported byNealon et al. (12) the storage stability of
human creatine kinase is profoundly affected by pH.
Thiol agents or chelators known to preserve creatine
Fig. 1.1-1.3. Thermal stability diagrams of creatine kinase iso-
enzymes in serum matrix at 37 °C. Initial enzyme
activities ranged from 350 to 550 U/l. All values
based on duplicates. No preservatives were added.
Before use the serum-enzyme mixtures were stored
overnight (4 °C) at neutral pH; after adjusting the
pH the samples were allowed to equilibrate for l h
(22 °C). Y-axis: Ratio of residual to initial activity.
J. Clin. Chem. Clin. Biochem. / Vol. 19,1981 / No. 10
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1.0
0.8
§0.6
.1 ÏË
Macro creatine kinase B B iRud.MJ
2.1
1.0
0.8
!0.6
0.2
5.5
2.2
Tab. 3. Heat inactivation of creatine kinase isoenzymes added to
native human serum, and of macro creatine kinases (23
different sera of 15 patients, 12 of type 1, 3 of type 2).
The pH of each sample was determined before test.
Activities were measured as duplicates before and after
heating for 20,40 and 60 minutes at 45 °C. The results
are expressed as ratio of residual to initial activity
(x±2s).
Time of Residual creatine kinase activity after heat inactivation
*
eat\ng MM MB BB Macro(mm)
(pH= (pH= (pH= (pH =
7.7 ±0.4) 7.7 ±0.4) 7.7 ±0.4) 7.9 ±0.5)
).2
Q
0
20
<!
 _
6.0 65 7.0 7.5 8.0 8.5 9.0 40
pH
60
1.00
0.75
(n =
0.56
0.40
(n*
±0.29
12)
±0.23
11)
±0.21
11)
1.00
0.32
(n =
0.18
(n =
0.12
(n =
± 0
14)
.11
±0.04
13)
± 0
13)
.04
1.00
0.12
(n =
0.08
(n =
0.07
(n =
±.0.09
14)
±0.05
±0.04
13)
1.00
0.80.±0.27
(n = 23)
0.69 ± 0.34
(n = 23)
0.62 ± 0.40
(n - 23)
Macro creatine kinase BB (Fro.M.)
240
360
6.0 6.5 7.0
pH
7.5 6.0 6.5
Fig. 2.1-2.2. Thermal stability diagrams of two macro creatine
kinases type 1 (sera Rud.M. and Fro.M.) at 37 °C.
Y-axis: Ratio of residual to initial activity.
Tab. 2. Effect of pH on the decay constants of two macro
creatine kinases type 1 (sera Rud.M. and Fro.M.) at
37 °C. The stability test was performed as described for
creatine kinase isoenzymes.
+: Activities increased slightly during the experiment
causing a negative result for the decay constant.
pH
6.00
6.51
7.14
7.41
7.92
8.67
Kd values, (h"1)
Macro creatine
kinase BB
(Rud.M.)
0.020
0.024
0.019
+
0.015
0.092
pH
6.10
6.40
6.79
7.32
7.67
8.19
Kd values (h"1)
Macro creatine
kinase B B
(Fro.M.)
0.120
0.028
0.033
0.081
0.134
0.245
1.2
1.0
r 0.8
ó
I
•0.6
ï
i
¼.4
0.2
Macro creatine
kinases
Creatine kinase M;B
Creatine kinase B B
Before After
heating at 45 °C for 20 min
Fig. 3. Heat inactivation of macro creatine kinase sera (n - 22,
17 of type 1,5 of type 2) and creatine kinase ispenzymes
BB and MB by incubation for 20 minutes at 45 °C. Before
and after heating, the creatine kinase activities of the sera
were determined after inhibition of the M-subunits by
antibodies. The hatched areas represent means and ± 2s-
ranges of residual creatine kinase BB and creatine kinase
MB activities.
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kinase activity give little or no protection above pH 7.5,
and at pH 8.5 they also contribute to enzyme instability.
Correspondingly in our in vitro experiments we found an
optimal stability for creatine kinase isoenzymes between
pH 6.5 and 7.0 at the physiological temperature of 37 °C,
with a dramatic loss of activities at lower and higher pH
values. The process of enzyme inactivation was con-
siderably more pronounced for creatine kinases BB and
MB than for creatine kinase MM.
Szasz et al. (13) described a rapid loss of the MM activity
in serum matrix without thiol protection and recovered
about 75, 50, and 10 percent of initial activities after 3,
6, and 24 h of storage at 37 °C. In this study the activ-
ities of creatine kinases MB and BB decreased to about
20 and 10 percent after 3 h, and to 10 and 5 percent
after 6 h of exposure to 37 °C. These half lives of crea-
tine kinase isoenzymes are consistent with our results
determined at basic pH values higher than pH 8.0. Mohn
(1) studied activity decay rates of creatine kinase iso-
enzymes under experimental conditions similar to those
presented here (37 °C, heat-inactivated serum as matrix)
but he also failed to define serum pH values. Therefore
his decay constants calculated for creatine kinase iso-
enzymes MM, MB, and BB (0.050,0.130 and 0.370 h"1)
are hardly comparable with our results. Kd-MB of Mohn
(1) is approximately consistent with our value, when
estimated at pH 7.5 (0.164 h'1). However, we determined
a remarkably lower Kd for isoenzyme MM (0.025), and
a higher one for BB (0.580 h"1). These discrepancies in
Kd values could be caused by a different preparation or
preexperimental storage of creatine kinase isoenzymes,
because a varying content of inactivated creatine kinase
molecules reactivated during the stability experiments
leads to falsely low Kd values. This, however, does not
explain the relatively higher Kd-BB determined in the
present work.
In this connection King et al. (14) studied the effect of
exercise on total serum creatine kinase activity in vivo
and found a clearly higher stability for creatine kinase
MM (Ka from 0.013 to 0.017 h"1); this corresponds
more closely with our results at optimal pH-values from
6.5 to 7.0 than with the latter investigations (Steele et
al. (15): 0.0516 h"1 \Norris et al. (16): 0.0426 h"1)
performed in vitro,
The high sensitivity of creatine kinase isoenzymes to pH
may be an important aspect in the enzymatic estimation
of the extent of myocardial infarct (17, 18). The release
of total creatine kinase and creatine kinase MB required
for the determination of infarct size depends directly on
Kd. Nevertheless Kd values of the cardiac specific iso-
enzyme MB measured by Harder et al. (19) were scattered
over a wide range from 0.050 to 0.139 h"1 in 14 individ-
ual cases, and Chäpelle et al. (20) found no significant
correlation between* the survival rate of patients and the
infarct size estimated by half life curves of creatine
kinase MB. The authors ascribed these findings to a
heterogenous distribution of the enzyme in myocardium.
In our opinion changes of blood pH occurring during
myocardial infarction must be included in the assessment
of the infarct size by enzymatic methods. Depending on
the extent of acidosis, Kd values of isoenzyme MB may
be decreased by a factor two to three (table 1), leading
to erronous results for the extent of myocardial necrosis.
Macro creatine kinase type 1 was proved to be immuno-
globulin G-linked (4-7) and a typical antigen-antibody
complex (21,22). During a further study concerning the
occurrence of macromolecular creatine kinase we de-
tected a second type, which differed in some physico-
chemical properties (electrophoretic mobility, elution
pattern on ion exchange chromatography, substrate
affinity towards creatine phosphate, activation energy)
from type 1 macro creatine kinase, and likewise is not
inhibited by anti-creatine kinase-M antibodies (9, 10).
We confirmed the thermal stability of macro creatine
kinase type 1 compared with that of creatine kinase BB
reported by others (4, 7). Additionally we determined
the Kd values and found that thermal stability is a com-
mon characteristic of both types of macro creatine
kinase. Furthermore, we ascertained that macro creatine
kinase is more stable when subjected to pH shifts. These
observations could explain the persistence of serum
creatine kinase activity in patients with macro creatine
kinasaemia (4,5,6, 7). Obviously macro creatine kinases
are also protected from in vivo degradation.
Free creatine kinase BB and macro creatine kinase in
patients' sera are the two well documented causes for a
false positive "CK-MB" test by the immunoinhibition
procedure (4, 5, 6, 7, 8, 23, 24, 25); therefore it may be
of diagnostic interest to separate both of the enzyme
forms. By the heating procedure macro creatine kinases
decreased to a minimum of 63 percent of the initial
activity, whereas the isoenzymes BB (MB) showed a
residual activity of 9 (38) percent at the most. We there-
fore propose a limit of 55 percent to discriminate macro
creatine kinases from thermoinstabile creatine kinase
isoenzymes (figure 3).
Clearly, the diagnosis of macro creatine kinase by heat
inactivation is limited by reduced sensitivity of the crea-
tine kinase assay at low serum enzyme activity. However,
we proved macro creatine kinase in one case with a low
total creatine kinase of 26 U/l (19 U/l after immuno-
inhibition). Furthermore the test may be disturbed if
creatine kinase BB (or MB) and macromolecular creatine
kinase both exist in a patient's serum - a probably rare
event.
Conclusion
For a diagnostic tool the heat inactivation test is simple
to perform in the routine laboratory, it completes
creatine kinase isoenzyme diagnosis by differentiating
thermostable macro creatine kinases and contributes to
the recognition of falsely positive "CK-MB" tests (ion
exchange chromatography, immunoinhibition) or un-
usual isoenzyme patterns in electrophoresis.
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